Bokus

Yeonwoo Lebovitz – författare

Visar alla böcker från författaren Yeonwoo Lebovitz. Handla med fri frakt och snabb leverans.

7 produkter

  1. and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Rebecca A. English, Yeonwoo Lebovitz, Robert B. Giffin - Transforming Clinical Research in the United States, E-bok. Tillgänglighet: Lägg i varukorg

    Transforming Clinical Research in the United States

    Challenges and Opportunities: Workshop Summary

    Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.

    E-bok, 2010

    500 kr

    Lägg i varukorg

    An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides …

  2. and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Yeonwoo Lebovitz, Rebecca A. English, Anne B. Claiborne - Building a National Framework for the Establishment of Regulatory Science for Drug Development, E-bok. Tillgänglighet: Lägg i varukorg

    Building a National Framework for the Establishment of Regulatory Science for Drug Development

    Workshop Summary

    Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.

    E-bok, 2011

    295 kr

    Lägg i varukorg

    The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA''s science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the …

  3. and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Academy of Science of South Africa, Steve Olson, Yeonwoo Lebovitz, Anne Claiborne - Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa, E-bok. Tillgänglighet: Lägg i varukorg

    Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

    Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa

    Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.

    E-bok, 2011

    491 kr

    Lägg i varukorg

    Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have developed drug resistance that makes their treatment more expensive, more toxic and less effective for the patient. The IOM Forum on Drug Discovery, …

  4. and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Rebecca A. English, Yeonwoo Lebovitz, Robert B. Giffin - Transforming Clinical Research in the United States, E-bok. Tillgänglighet: Lägg i varukorg

    Transforming Clinical Research in the United States

    Challenges and Opportunities: Workshop Summary

    Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.

    E-bok, 2010

    714 kr

    Lägg i varukorg

    An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides …

  5. and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Yeonwoo Lebovitz, Rebecca A. English, Anne B. Claiborne - Building a National Framework for the Establishment of Regulatory Science for Drug Development, E-bok. Tillgänglighet: Lägg i varukorg

    Building a National Framework for the Establishment of Regulatory Science for Drug Development

    Workshop Summary

    Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.

    E-bok, 2011

    428 kr

    Lägg i varukorg

    The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA''s science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the …

  6. and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Academy of Science of South Africa, Steve Olson, Yeonwoo Lebovitz, Anne Claiborne - Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa, E-bok. Tillgänglighet: Lägg i varukorg

    Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

    Global and Local Challenges and Solutions: Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa

    Av and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy m. fl.

    E-bok, 2011

    696 kr

    Lägg i varukorg

    Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have developed drug resistance that makes their treatment more expensive, more toxic and less effective for the patient. The IOM Forum on Drug Discovery, …

  7. Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Yeonwoo Lebovitz, Rebecca English, Anne Claiborne - Building a National Framework for the Establishment of Regulatory Science for Drug Development, Häftad. Tillgänglighet: Tillfälligt slut

    Building a National Framework for the Establishment of Regulatory Science for Drug Development

    Workshop Summary

    Av Institute of Medicine, Board on Health Sciences Policy m. fl.

    Häftad, 2011

    301 kr

    Tillfälligt slut

    The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the …